Penn Medicine’s flagship hospital noted zero central line-associated bloodstream infections in fiscal years 2022 and 2023, according to a study published Aug. 1 in Critical Care Nurse.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
